Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bristol-Myers Squibb (NY:BMY)

58.91 -0.46 (-0.78%)

Streaming Delayed Price Updated: 10:35 AM EDT, Mar 19, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,307,697
Open	59.21
Bid (Size)	58.90 (100)
Ask (Size)	58.91 (100)
Prev. Close	59.37
Today's Range	58.80 - 59.64
52wk Range	42.52 - 62.89
Shares Outstanding	2,222,113,553
Dividend Yield	4.28%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026

Today 6:59 EDT

From Bristol Myers Squibb

Via Business Wire

AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown

March 18, 2026

The pharmaceutical giant AbbVie (NYSE: ABBV) experienced a sharp decline on Wednesday, March 18, 2026, as its stock price tumbled to its lowest level since mid-2025. Shares of the Illinois-based...

Via MarketMinute

Performance

YTD	+10.2%	+10.2%
1 Month	-2.4%	-2.4%
3 Month	+10.0%	+10.0%
6 Month	+27.6%	+27.6%
1 Year	-1.7%	-1.7%

More News

Bristol‑Myers Squibb: The Boring Dividend Stock I'd Happily Hold Through Any Crash ↗

March 18, 2026

Via The Motley Fool

Bristol-Myers Squibb Co. (NYSE:BMY): A High-Yield Dividend Stock for Income Investors ↗

March 13, 2026

Via Chartmill

READYSTATE Dumps 361,000 Workiva Shares Worth $32 Million ↗

March 17, 2026

Via The Motley Fool

The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump

March 17, 2026

Via MarketMinute

Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026

March 16, 2026

Via MarketMinute

1 ETF That Could Turn $100 Per Month Into $67,380 ↗

March 15, 2026

Via The Motley Fool

1 S&P 500 Stock Worth Your Attention and 2 We Question

March 12, 2026

Via StockStory

BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier

March 10, 2026

Via MarketMinute

3 Healthcare Stocks Paying the Highest Dividends of 2026 ↗

March 10, 2026

Via The Motley Fool

Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma

March 09, 2026

From Bristol Myers Squibb

Via Business Wire

Why Bristol Myers Squibb Stock Crushed it in February ↗

March 08, 2026

Via The Motley Fool

U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis

March 06, 2026

From Bristol Myers Squibb

Via Business Wire

2 Top Healthcare Dividend Stocks to Buy and Hold Forever ↗

March 05, 2026

Via The Motley Fool

Q4 Earnings Outperformers: Bristol-Myers Squibb (NYSE:BMY) And The Rest Of The Branded Pharmaceuticals Stocks

March 04, 2026

Via StockStory

IBRX Stock Extends Rally To Day 3: Founder Drops ‘Prelude’ To 2025 Earnings, Slams Bristol Myers, Amgen Cancer Playbook ↗

March 03, 2026

Via Stocktwits

Bristol Myers Squibb Announces Dividend

March 02, 2026

From Bristol Myers Squibb

Via Business Wire

How to Spot Winning Innovation ↗

March 02, 2026

Via The Motley Fool

FourWorld Takes a Major Swing on Sable Offshore (SOC), Buying 8 Million Shares ↗

March 02, 2026

Via The Motley Fool

Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven‑Figure Retirement ↗

February 28, 2026

Via The Motley Fool

Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy

February 26, 2026

Via MarketMinute

SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

February 26, 2026

From Bristol Myers Squibb

Via Business Wire

Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics

February 25, 2026

Via MarketMinute

Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity

February 24, 2026

Via FinancialNewsMedia

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?

Yes, Bristol-Myers Squibb is publicly traded.

What exchange does Bristol-Myers Squibb trade on?

Bristol-Myers Squibb trades on the New York Stock Exchange

What is the ticker symbol for Bristol-Myers Squibb?

The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange

What is the current price of Bristol-Myers Squibb?

The current price of Bristol-Myers Squibb is 58.91

When was Bristol-Myers Squibb last traded?

The last trade of Bristol-Myers Squibb was at 03/19/26 10:35 AM ET

What is the market capitalization of Bristol-Myers Squibb?

The market capitalization of Bristol-Myers Squibb is 130.89B

How many shares of Bristol-Myers Squibb are outstanding?

Bristol-Myers Squibb has 131B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.